Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Spruce Biosciences (NASDAQ: SPRB) Reports Loss Per Share, Eyes Major Milestones

With a marketCapitalizationof approximately $128 million, the company has seen its shares decline by 48.3% year-to-date, reflecting investor concerns amid ongoing developmental risks and financial strain. These results signal a critical juncture as Spruce approaches key milestones tied to its TA-ERT program.

Vinay Lochav | 12 August 2026

Mineralys Therapeutics (NASDAQ: MLYS) Posts Q2 Loss, Builds $661M Cash Reserve

Mineralys Therapeutics (NASDAQ: MLYS) posted a second‑quarter loss. The company accumulated a $661 million cash balance. Shares traded, reflecting a volatile pattern in the biotech sector.

Vinay Lochav | 12 August 2026

Veradermics Reports Strong Cash Position as VDPHL01 Trials Progress Towards Key 2027 Data

Veradermics, Inc (NYSE: MANE) disclosed its quarterly financial results, highlighting a cash, cash equivalents and marketable securities balance of $819.9 million. This liquidity, coupled with the company’s capital raise of approximately $472.0 million, positions Veradermics to continue progressing its lead asset, VDPHL01.

Vinay Lochav | 12 August 2026

Xilio Therapeutics Reports $18.7M Revenue, Pipeline Advances (NASDAQ: XLO)

Xilio Therapeutics, Inc. (NASDAQ: XLO) reported second-quarter revenue of $18.7 million for the period ending June 30, 2026, marking a significant jump from $8.1 million during the same quarter last year. This strong revenue trajectory underscores the company’s capacity to grow amidst ongoing developmental …

Vinay Lochav | 12 August 2026

Trulieve Cannabis Corp. (NYSE: TRLV) Completes Domestication to Delaware, Enters Indemnification Agreements

Trulieve Cannabis Corp. has domesticated to Delaware, entering indemnification agreements with executives and directors, giving shareholders new rights and changing the corporate structure. This move affects investors holding shares, now valued at $9.31, up 6.9% year-to-date.Key HighlightsTrulieve Cannabis Corp. has filed a certificate of …

Vinay Lochav | 12 August 2026

TScan Therapeutics (NASDAQ: TCRX) Begins Phase 3 ALLOHA‑2 Dosing, Holds $100.2M Cash

TScan Therapeutics (NASDAQ: TCRX) dosed its inaugural patient in the Phase 3 ALLOHA‑2 trial for TSC‑101, a key step toward a readout expected mid‑2028. The company reported cash and cash equivalents of $100.2 million, sufficient to sustain its operating plan through the second quarter …

Vinay Lochav | 12 August 2026

Tenet Healthcare (NYSE: THC)’s Stock Climbs 30.1% Year-to-Date to $259.45 Amid Turnaround Efforts

Tenet Healthcare Corp (NYSE: THC). has seen its stock price stabilize at $259.45, marking a significant 30.1% appreciation this year as the company pushes its growth initiatives. Investors are encouraged by this upward trend after the stock had fluctuated within a 52-week range of …

Vinay Lochav | 12 August 2026

TimelyCare's Innovative Solutions Drive 104% Growth, Secure 2,964 Spot on Inc. 5000

TimelyCare, recognized as a leader in virtual healthcare, made headlines by ranking 2,964 on the Inc. 5000 list, reflecting a 104% revenue growth over three years. This recognition, which marks the fifth consecutive year on the list, underscores the increasing demand for accessible health …

Vinay Lochav | 12 August 2026

Sintx Technologies (NASDAQ: SINT) Anticipates Up to $1.3M Revenue in Q4 2026

Sintx Technologies, Inc. (NASDAQ: SINT) posted a second-quarter loss of $-0.75 per share, underperforming relative to the consensus estimate of $-0.69. This financial setback occurs amid a significant decline in the stock price, which has dropped by 53.2% year-to-date, suggesting a turbulent period ahead …

Vinay Lochav | 12 August 2026

Tango Therapeutics (NASDAQ: TNGX) Expands Stock Offering to $400M, Initiates New Phase

Tango Therapeutics, Inc. (NASDAQ: TNGX) has significantly raised its potential stock offering to an aggregate price of up to $400 million, following a successful prior program. Having previously raised an estimated $64 million, the company now aims to enhance its financial flexibility with this …

Vinay Lochav | 12 August 2026
Support

Hi! How can we help you today?

Loading…